California Stem Cell Inc., of Irvine, Calif., completed a Phase I trial of a cancer stem cell-based therapy, DC-TC in hepatocellular carcinoma. The trial, carried out in Shanghai, China, in accordance with international standards, was designed to determine safety in patients with Stage IV disease.